Prescott General Partners LLC - HUMACYTE INC ownership

HUMACYTE INC's ticker is and the CUSIP is 44486Q103. A total of 123 filers reported holding HUMACYTE INC in Q2 2024. The put-call ratio across all filers is 1.80 and the average weighting 0.0%.

Quarter-by-quarter ownership
Prescott General Partners LLC ownership history of HUMACYTE INC
ValueSharesWeighting
Q1 2024$1,767,245
+9.5%
568,2460.0%0.10%
+5.4%
Q4 2023$1,613,819
-3.1%
568,2460.0%0.09%
-12.3%
Q3 2023$1,664,961
+2.4%
568,2460.0%0.11%
+6.0%
Q2 2023$1,625,184
-7.4%
568,2460.0%0.10%
-28.1%
Q1 2023$1,755,880
+46.4%
568,2460.0%0.14%
+43.3%
Q4 2022$1,198,999
-35.3%
568,2460.0%0.10%
-33.1%
Q3 2022$1,852,000
+1.5%
568,2460.0%0.14%
+16.0%
Q2 2022$1,824,000
-58.7%
568,246
-9.1%
0.12%
-37.8%
Q1 2022$4,413,000
+660.9%
625,100
+681.4%
0.20%
+905.0%
Q4 2021$580,00080,0000.02%
Other shareholders
HUMACYTE INC shareholders Q2 2024
NameSharesValueWeighting ↓
Endowment Wealth Management, Inc. 100,518$482,4860.35%
Monashee Investment Management LLC 280,000$1,344,0000.17%
United Asset Strategies, Inc. 218,308$1,047,8780.10%
HAMILTON LANE ADVISORS LLC 21,893$105,0860.08%
GSA CAPITAL PARTNERS LLP 224,179$1,0760.08%
David J Yvars Group 22,750$109,2000.07%
ARS Investment Partners, LLC 116,419$558,8110.05%
EntryPoint Capital, LLC 5,180$24,8640.04%
Virtu Financial LLC 103,163$4950.04%
Anson Funds Management LP 50,000$240,0000.03%
View complete list of HUMACYTE INC shareholders